Hemophilia laboratory findings

Jump to navigation Jump to search

Hemophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia laboratory findings

CDC on Hemophilia laboratory findings

Hemophilia laboratory findings in the news

Blogs on Hemophilia laboratory findings

Directions to Hospitals Treating Hemophilia

Risk calculators and risk factors for Hemophilia laboratory findings

Screening Tests

Screening tests are blood tests that show if the blood is clotting properly. Types of screening tests:

Complete Blood Count (CBC)

This common test measures the amount of hemoglobin (the red pigment inside red blood cells that carries oxygen), the size and number of red blood cells and numbers of different types of white blood cells and platelets found in blood. The CBC is normal in people with hemophilia. However, if a person with hemophilia has unusually heavy bleeding or bleeds for a long time, the hemoglobin and the red blood cell count can be low.

Activated Partial Thromboplastin Time (APTT) Test

This test measures how long it takes for blood to clot. It measures the clotting ability of factors VIII (8), IX (9), XI (11), and XII (12). If any of these clotting factors are too low, it takes longer than normal for the blood to clot. The results of this test will show a longer clotting time among people with hemophilia A or B.

Prothrombin Time (PT) Test

This test also measures the time it takes for blood to clot. It measures primarily the clotting ability of factors I (1), II (2), V (5), VII (7), and X (10). If any of these factors are too low, it takes longer than normal for the blood to clot. The results of this test will be normal among most people with hemophilia A and B.

Fibrinogen Test

This test also helps doctors assess a patient’s ability to form a blood clot. This test is ordered either along with other blood clotting tests or when a patient has an abnormal PT or APTT test result, or both. Fibrinogen is another name for clotting factor I (1).

Clotting Factor Tests

Clotting factor tests, also called factor assays, are required to diagnose a bleeding disorder. This blood test shows the type of hemophilia and the severity. It is important to know the type and severity in order to create the best treatment plan.

Condition Prothrombin time Partial Thromboplastin Time Bleeding Time Platelet Count
Heamophilia A or B Unaffected Prolonged Unaffected Unaffected
Von Willebrand Disease Unaffected Prolonged or Unaffected Prolonged Unaffected
Thrombocytopenia Unaffected Unaffected Prolonged Decreased
Adapted from CDC Hemophilia Diagnosis> "CDC Hemophilia Diagnosis".


Severity Levels of Factor VIII (8)

or IX (9) in the blood

Normal (person who does not have hemophilia) 50% to 100%
Mild hemophilia Greater than 5% but less than 50%
Moderate hemophilia 1% to 5%
Severe hemophilia Less than 1%
Adapted from CDC Hemophilia Diagnosis> "CDC Hemophilia Diagnosis".

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:WH Template:WS